Company profile MACK

Merrimack Pharmaceuticals Inc
merrimack is a fully integrated biopharmaceutical company that views cancer as a complex engineering challenge. through systems biology, which brings together the fields of biology, computing and engineering, merrimack aims to decrease uncertainty in drug development and clinical validation, and move discovery efforts beyond trial and error. such an approach has the potential t...o make individualized treatment of patients a reality. merrimack's first commercial product, onivydetm (irinotecan liposome injection), was approved by the u.s. fda on october 22, 2015. with four additional candidates in clinical studies, several in preclinical development and multiple biomarkers designed to support patient selection, merrimack is building one of the most robust oncology pipelines in the industry. for more information, please visit merrimack's website at www.merrimack.com or connect on twitter at @merrimackpharma. Show More
Quarter analysis & expected interestLast update: February 08 2024 00:37:43.

After 38 days of this quarter the interest is at 56.0. Based on that we can calculate that during remaining 53 days it will total up to 134.0.
Merrimack Pharmaceuticals expected interest is significantly higher compared to previous quarter (+52.3%) and same quarter last year (+185.1%).

YearQ1Q2Q3Q4
201954
348
544.4% QoQ
282
-19.0% QoQ
15
-94.7% QoQ
2020 164
203.7% YoY 993.3% QoQ
133
-61.8% YoY -18.9% QoQ
90
-68.1% YoY -32.3% QoQ
158
953.3% YoY 75.6% QoQ
2021 112
-31.7% YoY -29.1% QoQ
133
0.0% YoY 18.8% QoQ
65
-27.8% YoY -51.1% QoQ
104
-34.2% YoY 60.0% QoQ
2022 133
18.8% YoY 27.9% QoQ
18
-86.5% YoY -86.5% QoQ
156
140.0% YoY 766.7% QoQ
229
120.2% YoY 46.8% QoQ
2023 47
-64.7% YoY -79.5% QoQ
90
400.0% YoY 91.5% QoQ
97
-37.8% YoY 7.8% QoQ
88
-61.6% YoY -9.3% QoQ
2024 56
19.1% YoY -36.4% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Merrimack Pharmaceuticals search interestLast update: February 08 2024 00:37:43.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 00:37:44.

The average 5 years interest of Merrimack Pharmaceuticals was 9.89 per week.
The last year interest of Merrimack Pharmaceuticals compared to the last 5 years has changed by -33.06%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -53.22%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: November 09 2023 13:54:07.

After 34 days of this quarter the interest is at 14.0. Based on that we can calculate that during remaining 58 days it will total up to 38.0.
biopharmaceutical company expected interest is significantly lower compared to previous quarter (-57.8%) and same quarter last year (-72.5%).

YearQ1Q2Q3Q4
2018 - - - 127
2019 118
-7.1% QoQ
78
-33.9% QoQ
153
96.2% QoQ
205
61.4% YoY 34.0% QoQ
2020 101
-14.4% YoY -50.7% QoQ
226
189.7% YoY 123.8% QoQ
71
-53.6% YoY -68.6% QoQ
38
-81.5% YoY -46.5% QoQ
2021 84
-16.8% YoY 121.1% QoQ
188
-16.8% YoY 123.8% QoQ
58
-18.3% YoY -69.1% QoQ
87
128.9% YoY 50.0% QoQ
2022 170
102.4% YoY 95.4% QoQ
75
-60.1% YoY -55.9% QoQ
134
131.0% YoY 78.7% QoQ
138
58.6% YoY 3.0% QoQ
2023 118
-30.6% YoY -14.5% QoQ
54
-28.0% YoY -54.2% QoQ
90
-32.8% YoY 66.7% QoQ
14
-89.9% YoY -84.4% QoQ
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and biopharmaceutical company search interestLast update: November 09 2023 13:54:06.
Correlation coefficient between keyword and revenue is 0.84
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: November 09 2023 13:54:07.

The average 5 years interest of biopharmaceutical company was 8.92 per week.
The last year interest of biopharmaceutical company compared to the last 5 years has changed by -26.91%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -43.79%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Merrimack Pharmaceuticals profile to provide analysis

Correlation between past revenue and Merrimack Pharmaceuticals profile search interest

There is not enough data for Merrimack Pharmaceuticals profile to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Merrimack Pharmaceuticals profile to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Merrimack Pharmaceuticals facts to provide analysis

Correlation between past revenue and Merrimack Pharmaceuticals facts search interest

There is not enough data for Merrimack Pharmaceuticals facts to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Merrimack Pharmaceuticals facts to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 00:37:47.

After 38 days of this quarter the interest is at 16.0. Based on that we can calculate that during remaining 53 days it will total up to 38.0.
Merrimack Pharmaceuticals news expected interest is significantly higher compared to same quarter last year (+65.2%) but similar to previous quarter.

YearQ1Q2Q3Q4
201982
42
-48.8% QoQ
97
131.0% QoQ
17
-82.5% QoQ
2020 20
-75.6% YoY 17.6% QoQ
120
185.7% YoY 500.0% QoQ
53
-45.4% YoY -55.8% QoQ
100
488.2% YoY 88.7% QoQ
2021 41
105.0% YoY -59.0% QoQ
43
-64.2% YoY 4.9% QoQ
132
149.1% YoY 207.0% QoQ
72
-28.0% YoY -45.5% QoQ
2022 146
256.1% YoY 102.8% QoQ
50
16.3% YoY -65.8% QoQ
101
-23.5% YoY 102.0% QoQ
128
77.8% YoY 26.7% QoQ
2023 23
-84.2% YoY -82.0% QoQ
31
-38.0% YoY 34.8% QoQ
69
-31.7% YoY 122.6% QoQ
54
-57.8% YoY -21.7% QoQ
2024 16
-30.4% YoY -70.4% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Merrimack Pharmaceuticals news search interestLast update: February 08 2024 00:37:46.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 00:37:47.

The average 5 years interest of Merrimack Pharmaceuticals news was 5.53 per week.
The last year interest of Merrimack Pharmaceuticals news compared to the last 5 years has changed by -32.91%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -19.0%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Merrimack Pharmaceuticals CEO to provide analysis

Correlation between past revenue and Merrimack Pharmaceuticals CEO search interest

There is not enough data for Merrimack Pharmaceuticals CEO to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Merrimack Pharmaceuticals CEO to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Merrimack Pharmaceuticals headquarters to provide analysis

Correlation between past revenue and Merrimack Pharmaceuticals headquarters search interest

There is not enough data for Merrimack Pharmaceuticals headquarters to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Merrimack Pharmaceuticals headquarters to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Merrimack Pharmaceuticals stock price to provide analysis

Correlation between past revenue and Merrimack Pharmaceuticals stock price search interest

There is not enough data for Merrimack Pharmaceuticals stock price to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Merrimack Pharmaceuticals stock price to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Merrimack Pharmaceuticals financials to provide analysis

Correlation between past revenue and Merrimack Pharmaceuticals financials search interest

There is not enough data for Merrimack Pharmaceuticals financials to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Merrimack Pharmaceuticals financials to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for MACK
Earnings date: 2024-03-06 After close
Company name: Merrimack Pharmaceuticals Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2024-05-20T16:05:28-04:00

SEC
15-12G Form - Securities registration termination [Section 12(g)] - MERRIMACK PHARMACEUTICALS INC (0001274792) (Filer)

2024-05-15T16:15:28-04:00

SEC
10-Q Form - Quarterly report [Sections 13 or 15(d)] - MERRIMACK PHARMACEUTICALS INC (0001274792) (Filer)

2024-05-14T06:20:00Z

AccessWire
Vicore Expands and Strengthens its Board of Directors

2024-05-10T16:45:35-04:00

SEC
25 Form - Notification of the removal from listing and registration of matured, redeemed or retired securities - MERRIMACK PHARMACEUTICALS INC (0001274792) (Filer)

2024-05-10T16:43:01-04:00

SEC
8-K Form - Current report, items 5.07, 7.01, and 9.01 - MERRIMACK PHARMACEUTICALS INC (0001274792) (Filer)

2024-05-10T20:30:00Z

BusinessWire
Merrimack Pharmaceuticals, Inc. Announces Stockholder Approval of Plan of Dissolution And Cash Liquidating Dividend Amount of $15.10 Per Share of Common Stock

2024-05-09T07:45:25-04:00

SEC
DEFA14A Form - Additional definitive proxy soliciting materials and Rule 14(a)(12) material - MERRIMACK PHARMACEUTICALS INC (0001274792) (Filer)

2024-05-09T07:43:00-04:00

SEC
8-K Form - Current report, items 7.01 and 9.01 - MERRIMACK PHARMACEUTICALS INC (0001274792) (Filer)

2024-05-09T11:30:00Z

BusinessWire
Merrimack Pharmaceuticals, Inc. Announces Anticipated Final Cash Dividend Amount of Initial Liquidating Distribution, Subject to Receipt of Stockholder Approval of Plan of Dissolution

2024-04-30T17:24:02-04:00

SEC
DEFA14A Form - Additional definitive proxy soliciting materials and Rule 14(a)(12) material - MERRIMACK PHARMACEUTICALS INC (0001274792) (Filer)

2024-04-30T17:22:00-04:00

SEC
8-K Form - Current report, items 3.01, 7.01, and 9.01 - MERRIMACK PHARMACEUTICALS INC (0001274792) (Filer)

2024-04-30T21:15:00Z

BusinessWire
Merrimack Pharmaceuticals Announces Notification of Plan to Voluntary Delist Common Stock on NASDAQ Subject to Receipt of Stockholder Approval of Plan of Dissolution

2024-04-01T16:28:49-04:00

SEC
DEFR14A Form - Revised definitive proxy soliciting materials - MERRIMACK PHARMACEUTICALS INC (0001274792) (Filer)

2024-03-27T17:00:02-04:00

SEC
DEFA14A Form - Additional definitive proxy soliciting materials and Rule 14(a)(12) material - MERRIMACK PHARMACEUTICALS INC (0001274792) (Filer)

2024-03-27T16:57:54-04:00

SEC
8-K Form - Current report, items 7.01 and 9.01 - MERRIMACK PHARMACEUTICALS INC (0001274792) (Filer)